These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 31389310)
1. In Vitro Immunodetection of Prothymosin Alpha in Normal and Pathological Conditions. Karachaliou CE; Kalbacher H; Voelter W; Tsitsilonis OE; Livaniou E Curr Med Chem; 2020; 27(29):4840-4854. PubMed ID: 31389310 [TBL] [Abstract][Full Text] [Related]
2. Prothymosin Alpha: An Alarmin and More.. Samara P; Karachaliou CE; Ioannou K; Papaioannou NE; Voutsas IF; Zikos C; Pirmettis I; Papadopoulos M; Kalbacher H; Livaniou E; Tsitsilonis OE; Voelter W Curr Med Chem; 2017; 24(17):1747-1760. PubMed ID: 28521686 [TBL] [Abstract][Full Text] [Related]
3. Immunocytological and preliminary immunohistochemical studies of prothymosin alpha, a human cancer-associated polypeptide, with a well-characterized polyclonal antibody. Klimentzou P; Drougou A; Fehrenbacher B; Schaller M; Voelter W; Barbatis C; Paravatou-Petsotas M; Livaniou E J Histochem Cytochem; 2008 Nov; 56(11):1023-31. PubMed ID: 18711212 [TBL] [Abstract][Full Text] [Related]
4. [Prothymosin alpha and tumor: current status and perspective]. Wang M; Pan JY Ai Zheng; 2007 Mar; 26(3):333-6. PubMed ID: 17355803 [TBL] [Abstract][Full Text] [Related]
5. Development and immunochemical evaluation of antibodies Y for the poorly immunogenic polypeptide prothymosin alpha. Klimentzou P; Paravatou-Petsotas M; Zikos C; Beck A; Skopeliti M; Czarnecki J; Tsitsilonis O; Voelter W; Livaniou E; Evangelatos GP Peptides; 2006 Jan; 27(1):183-93. PubMed ID: 16150512 [TBL] [Abstract][Full Text] [Related]
7. Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications? Samara P; Ioannou K; Tsitsilonis OE Vitam Horm; 2016; 102():179-207. PubMed ID: 27450735 [TBL] [Abstract][Full Text] [Related]
8. The immunologically active site of prothymosin alpha is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients. Skopeliti M; Voutsas IF; Klimentzou P; Tsiatas ML; Beck A; Bamias A; Moraki M; Livaniou E; Neagu M; Voelter W; Tsitsilonis OE Cancer Immunol Immunother; 2006 Oct; 55(10):1247-57. PubMed ID: 16453152 [TBL] [Abstract][Full Text] [Related]
9. Involvement of SNARE Protein Interaction for Non-classical Release of DAMPs/Alarmins Proteins, Prothymosin Alpha and S100A13. Matsunaga H; Halder SK; Ueda H Cell Mol Neurobiol; 2021 Nov; 41(8):1817-1828. PubMed ID: 32856232 [TBL] [Abstract][Full Text] [Related]
10. Development of an ELISA for the quantification of the C-terminal decapeptide prothymosin α(100-109) in sera of mice infected with bacteria. Samara P; Kalbacher H; Ioannou K; Radu DL; Livaniou E; Promponas VJ; Voelter W; Tsitsilonis O J Immunol Methods; 2013 Sep; 395(1-2):54-62. PubMed ID: 23831611 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of Prothymosin α. An Approach to Its Biological Significance. Freire M; Sarandeses CS; Covelo G; Díaz-Jullien C Vitam Horm; 2016; 102():73-99. PubMed ID: 27450731 [TBL] [Abstract][Full Text] [Related]
12. Regional distribution and cell type-specific subcellular localization of Prothymosin alpha in brain. Halder SK; Ueda H Cell Mol Neurobiol; 2012 Jan; 32(1):59-66. PubMed ID: 21750924 [TBL] [Abstract][Full Text] [Related]
13. Prothymosin α interacts with SET, ANP32A and ANP32B and other cytoplasmic and mitochondrial proteins in proliferating cells. Barbeito P; Sarandeses CS; Díaz-Jullien C; Muras J; Covelo G; Moreira D; Freire-Cobo C; Freire M Arch Biochem Biophys; 2017 Dec; 635():74-86. PubMed ID: 29106904 [TBL] [Abstract][Full Text] [Related]
15. Prothymosin alpha is a chromatin-remodelling protein in mammalian cells. Gomez-Marquez J; Rodríguez P Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):1-3. PubMed ID: 9639554 [TBL] [Abstract][Full Text] [Related]
16. Characterization of two thymosins as immune-related genes in common carp (Cyprinus carpio L.). Xiao Z; Shen J; Feng H; Liu H; Wang Y; Huang R; Guo Q Dev Comp Immunol; 2015 May; 50(1):29-37. PubMed ID: 25596145 [TBL] [Abstract][Full Text] [Related]
17. Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition. Fujita R; Ueda M; Fujiwara K; Ueda H Cell Death Differ; 2009 Feb; 16(2):349-58. PubMed ID: 18989338 [TBL] [Abstract][Full Text] [Related]
18. Development of a specific IgY-based ELISA for prothymosin alpha, a bioactive polypeptide with diagnostic and therapeutic potential. Karachaliou CE; Kostopoulos IV; Vassilakopoulou V; Klimentzou P; Paravatou-Petsotas M; Voelter W; Kalbacher H; Zikos C; Tsitsilonis O; Livaniou E Heliyon; 2019 Oct; 5(10):e02616. PubMed ID: 31720448 [TBL] [Abstract][Full Text] [Related]
19. Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy. Ioannou K; Samara P; Livaniou E; Derhovanessian E; Tsitsilonis OE Cancer Immunol Immunother; 2012 May; 61(5):599-614. PubMed ID: 22366887 [TBL] [Abstract][Full Text] [Related]
20. Fifteen years of prothymosin alpha: contradictory past and new horizons. Piñeiro A; Cordero OJ; Nogueira M Peptides; 2000 Sep; 21(9):1433-46. PubMed ID: 11072132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]